2-MABB
| Clinical data | |
|---|---|
| Other names | 2-(2-(Methylamino)butyl)benzofuran |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C13H17NO |
| Molar mass | 203.285 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2-MABB, also known as 2-(2-(methylamino)butyl)benzofuran, is a psychoactive drug of the substituted benzofuran family.[1][2][3][4] It was encountered as a novel designer drug in Europe in 2016.[4] The drug has been made a controlled substance in Sweden, Italy, and Russia.[1][2][3]
See also
References
- ^ a b "2-MABB". AIPSIN Drugs (in Russian). Retrieved 3 February 2026.
- ^ a b "2-MABB". AIPSIN Drugs (in Russian).
- ^ a b Di Luca NM, Busardò FP, Pirani F, Varì MR (2020). "Evolution of Italian laws banning trafficking, use and abuse of psychotropic drugs". Annali Dell'Istituto Superiore Di Sanita. 56 (1): 76–89. doi:10.4415/ANN_20_01_12. PMID 32242539.
- ^ a b Annual Report on the implementation of Council Decision 2005/387/JHA. EMCDDA–Europol (Report). 2016.